相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of human mitogen-activated protein kinase 15 (extracellular signal-regulated kinase 7/8) and its functions: A recent update
Andy T. Y. Lau et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Lasting DNA Damage and Aberrant DNA Repair Gene Expression Profile Are Associated with Post-Chronic Cadmium Exposure in Human Bronchial Epithelial Cells
Heng Wee Tan et al.
CELLS (2019)
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
Iman W. Achkar et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer
Na-Li Cai et al.
PLOS ONE (2017)
Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide
Dan-Dan Wu et al.
ONCOTARGET (2017)
TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells
Xiao Wu et al.
CANCER CELL INTERNATIONAL (2017)
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
D. A. Fennell et al.
CANCER TREATMENT REVIEWS (2016)
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors
Matteo Rossi et al.
ONCOTARGET (2016)
TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas
Koen M. O. Galenkamp et al.
MOLECULAR CANCER (2015)
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
Ivana Sullivan et al.
CANCER LETTERS (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Regulation of NF-κB by TNF family cytokines
Matthew S. Hayden et al.
SEMINARS IN IMMUNOLOGY (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
TNF-α-mediated NF-κB survival signaling impairment by cisplatiri enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells
Giulia Benedetti et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Extracellular Signal-regulated Kinase 8 (ERK8) Controls Estrogen-related Receptor α (ERRα) Cellular Localization and Inhibits Its Transcriptional Activity
Matteo Rossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Crosstalk in NF-κB signaling pathways
Andrea Oeckinghaus et al.
NATURE IMMUNOLOGY (2011)
Extracellular Signal-Regulated Kinase 8-Mediated c-Jun Phosphorylation Increases Tumorigenesis of Human Colon Cancer
Yan-Ming Xu et al.
CANCER RESEARCH (2010)
Focus on histone variant H2AX: To be or not to be
Jingsong Yuan et al.
FEBS LETTERS (2010)
Evaluation of curcumin and cisplatin-induced DNA damage in PC12 cells by the alkaline comet assay
Leonardo Meneghin Mendonca et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2010)
A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA
Angela L. Groehler et al.
JOURNAL OF CELL BIOLOGY (2010)
Regulation of the activity and expression of ERK8 by DNA damage
Iva V. Klevernic et al.
FEBS LETTERS (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells
B. Zhang et al.
KIDNEY INTERNATIONAL (2007)
In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds
Fabrice Nesslany et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2007)
Cell apoptosis: Requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3
Chengrong Lu et al.
MOLECULAR CELL (2006)
ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5
Matthew P. Saelzler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene
C Iavarone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Characterization of the reversible phosphorylation and activation of ERK8
IV Klevernic et al.
BIOCHEMICAL JOURNAL (2006)
Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay
GM Almeida et al.
DNA REPAIR (2006)
The comet assay: a method to measure DNA damage in individual cells
Peggy L. Olive et al.
NATURE PROTOCOLS (2006)
Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP
B Kosmider et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2004)
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
G Ramesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction
LM Henrich et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
G Ramesh et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
ERK-8, a new member of the mitogen-activated protein kinase family
MK Abe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Requirement for ERK activation in cisplatin-induced apoptosis
XT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
